Severe scalp ulcerations and granulomata during treatment with amivantamab

Severe scalp ulcerations and granulomata during treatment with amivantamab

This case series of 9 patients with NSCLC is the first to detail the presentation and treatment of ulcerative scalp lesions associated with amivantamab, a bispecific antibody which targets both epithelial growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET). At our instit...

Full description

Bibliographic Details
Main Authors: Jingjia J Zhou, Lanyi N Chen, Thomas Lehan, Benjamin Herzberg, Brian S Henick, Michael Pitman, Stephanie Gallitano, Catherine A Shu
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Amivantamab
Lazertinib
Scalp
Ulcer
Case report
Online Access:http://www.sciencedirect.com/science/article/pii/S2666621923000571

Internet

http://www.sciencedirect.com/science/article/pii/S2666621923000571

Similar Items